CHE Stock Overview
Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Chemed Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$578.03 |
| 52 Week High | US$654.62 |
| 52 Week Low | US$492.84 |
| Beta | 0.43 |
| 11 Month Change | 6.45% |
| 3 Month Change | 3.57% |
| 1 Year Change | 15.26% |
| 33 Year Change | 24.31% |
| 5 Year Change | 36.90% |
| Change since IPO | 5,009.66% |
Recent News & Updates
Recent updates
Chemed Remains A Buy On Long-Term Economics
Aug 16Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon
Jul 19
Chemed: Growth Does Not Justify The Current Stock Price
May 20Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns
May 14Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?
Apr 26Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year
Mar 01The Price Is Right For Chemed Corporation (NYSE:CHE)
Dec 30Chemed: Continues To Compound Shareholder Value At Double-Digit Returns
Nov 30Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns
Oct 26Chemed - Showcasing Why It's So Reliable
Aug 26Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked
Aug 13Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?
Aug 01Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
Jul 14Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet
Jun 07Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns
Apr 09Chemed Q4 2022 Earnings Preview
Feb 22Chemed Corporation: Long-Term Tailwinds, But Remains A Hold
Feb 14Is Chemed (NYSE:CHE) Using Too Much Debt?
Jan 05Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean
Dec 17Chemed declares $0.38 dividend
Nov 04Chemed Q3 2022 Earnings Preview
Oct 28Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?
Oct 01Capital Investment Trends At Chemed (NYSE:CHE) Look Strong
Sep 16Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns
Aug 26A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)
Aug 16Chemed declares $0.38 dividend
Aug 05Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range
Jul 27Shareholder Returns
| CHE | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.8% | 1.6% | 3.1% |
| 1Y | 15.3% | 12.4% | 25.4% |
Return vs Industry: CHE exceeded the US Healthcare industry which returned 11.5% over the past year.
Return vs Market: CHE underperformed the US Market which returned 25.6% over the past year.
Price Volatility
| CHE volatility | |
|---|---|
| CHE Average Weekly Movement | 2.5% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: CHE has not had significant price volatility in the past 3 months.
Volatility Over Time: CHE's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 15,087 | Kevin McNamara | www.chemed.com |
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Chemed Corporation Fundamentals Summary
| CHE fundamental statistics | |
|---|---|
| Market cap | US$8.66b |
| Earnings (TTM) | US$300.92m |
| Revenue (TTM) | US$2.34b |
28.8x
P/E Ratio3.7x
P/S RatioIs CHE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHE income statement (TTM) | |
|---|---|
| Revenue | US$2.34b |
| Cost of Revenue | US$1.50b |
| Gross Profit | US$839.98m |
| Other Expenses | US$539.06m |
| Earnings | US$300.92m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 20.07 |
| Gross Margin | 35.96% |
| Net Profit Margin | 12.88% |
| Debt/Equity Ratio | 0% |
How did CHE perform over the long term?
See historical performance and comparison